{"name": "Acute Uncomplicated Cystitis","source": "International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. \nFigure 1. Approach to choosing an optimal antimicrobial agent for empirical treatment of acute uncomplicated cystitis. DS, double-strength; UTI, urinary tract infection.","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","children": [{"name": "Diagnose AUC","description": "Woman with acute uncomplicated cystitis:\n\t- Absence of fever, flank pain, or other suspicion for pyelonephritis\n\t- Able to take oral medication\n","node_type": "decision_node","workflow_state": "inactiveState","decisional_state": "chosenState","children": [{"name": "Alternate diagnosis","description": "Consider alternate diagnosis (such as pyelonephritis or complicated UTI) & treat accordingly (see text)","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "negative"},{"name": "Antimicrobial treatment","description": "Can one of the recommended antimicrobials* below be used considering:\n\t- Availability\n\t- Allergy history\n\t- Tolerance\n\n*The choice between these agents should be individualized and based on patient allergy and compliance history, \nlocal practice patterns, local community resistance prevalence, availability, cost, and patient and provider threshold for failure (see Table 4).","node_type": "decision_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "positive","children": [{"name": "Non-recommended antimicrobials","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "use other"},{"name": "Early pyelonephritis?","node_type": "decision_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "use recommended","children": [{"name": "No early pyelonephritis","node_type": "decision_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "no","children": [{"name": "Pivmecillinam","description": "Pivmecillinam 400 mg bid x 5 days (lower efficacy than some other recommended agents; avoid if early pyelonephritis suspected)","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "option3"},{"name": "Fosfomycin trometamol","description": "Fosfomycin trometamol 3 gm single dose (lower efficacy than some other recommended agents; avoid if early pyelonephritis suspected)","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "option2"},{"name": "Nitrofurantoin","description": "Nitrofurantoin monohydrate\/macrocrystals 100mg bid X 5 days (avoid if early pyelonephritis suspected)","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "option1"}]},{"name": "Trimethoprim-sulfamethoxazole","description": "Trimethoprim-sulfamethoxazole 160\/800 mg (one DS tablet) bid X 3 days (avoid if resistance prevalence is known to exceed 20 or if used for UTI in previous 3 months)","node_type": "task_node","workflow_state": "inactiveState","decisional_state": "chosenState","condition": "yes"}]}]}]}]}